Literature DB >> 33604303

Comparison of Radiomic Models Based on Low-Dose and Standard-Dose CT for Prediction of Adenocarcinomas and Benign Lesions in Solid Pulmonary Nodules.

Jieke Liu1, Hao Xu1, Haomiao Qing1, Yong Li1, Xi Yang1, Changjiu He1, Jing Ren1, Peng Zhou1.   

Abstract

OBJECTIVES: This study aimed to develop radiomic models based on low-dose CT (LDCT) and standard-dose CT to distinguish adenocarcinomas from benign lesions in patients with solid solitary pulmonary nodules and compare the performance among these radiomic models and Lung CT Screening Reporting and Data System (Lung-RADS). The reproducibility of radiomic features between LDCT and standard-dose CT were also evaluated.
METHODS: A total of 141 consecutive pathologically confirmed solid solitary pulmonary nodules were enrolled including 50 adenocarcinomas and 48 benign nodules in primary cohort and 22 adenocarcinomas and 21 benign nodules in validation cohort. LDCT and standard-dose CT scans were conducted using same acquisition parameters and reconstruction method except for radiation dose. All nodules were automatically segmented and 104 original radiomic features were extracted. The concordance correlation coefficient was used to quantify reproducibility of radiomic features between LDCT and standard-dose CT. Radiomic features were selected to build radiomic signature, and clinical characteristics and radiomic signature were combined to develop radiomic nomogram for LDCT and standard-dose CT, respectively. The performance of radiomic models and Lung-RADS was assessed by area under curve (AUC) of receiver operating characteristic curve, sensitivity, and specificity.
RESULTS: Shape and first order features, and neighboring gray tone difference matrix features were highly reproducible between LDCT and standard-dose CT. No significant differences of AUCs were found among radiomic signature and nomogram of LDCT and standard-dose CT in both primary and validation cohort (0.915 vs. 0.919 vs. 0.898 vs. 0.909 and 0.976 vs. 0.976 vs. 0.985 vs. 0.987, respectively). These radiomic models had higher specificity than Lung-RADS (all correct P < 0.05), while there were no significant differences of sensitivity between Lung-RADS and radiomic models.
CONCLUSIONS: The diagnostic performance of LDCT-based radiomic models to differentiate adenocarcinomas from benign lesions in solid pulmonary nodules were equivalent to that of standard-dose CT. The LDCT-based radiomic model with higher specificity and lower false-positive rate than Lung-RADS might help reduce overdiagnosis and overtreatment of solid pulmonary nodules in lung cancer screening.
Copyright © 2021 Liu, Xu, Qing, Li, Yang, He, Ren and Zhou.

Entities:  

Keywords:  benign lesion; low-dose computed tomography; lung adenocarcinoma; lung cancer screening; radiomics; solid pulmonary nodule

Year:  2021        PMID: 33604303      PMCID: PMC7884759          DOI: 10.3389/fonc.2020.634298

Source DB:  PubMed          Journal:  Front Oncol        ISSN: 2234-943X            Impact factor:   6.244


  50 in total

1.  Selection of important variables and determination of functional form for continuous predictors in multivariable model building.

Authors:  Willi Sauerbrei; Patrick Royston; Harald Binder
Journal:  Stat Med       Date:  2007-12-30       Impact factor: 2.373

2.  Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach.

Authors:  E R DeLong; D M DeLong; D L Clarke-Pearson
Journal:  Biometrics       Date:  1988-09       Impact factor: 2.571

3.  US lung cancer trends by histologic type.

Authors:  Denise Riedel Lewis; David P Check; Neil E Caporaso; William D Travis; Susan S Devesa
Journal:  Cancer       Date:  2014-08-11       Impact factor: 6.860

4.  Quantitative Features of Liver Lesions, Lung Nodules, and Renal Stones at Multi-Detector Row CT Examinations: Dependency on Radiation Dose and Reconstruction Algorithm.

Authors:  Justin Solomon; Achille Mileto; Rendon C Nelson; Kingshuk Roy Choudhury; Ehsan Samei
Journal:  Radiology       Date:  2015-12-01       Impact factor: 11.105

5.  Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial.

Authors:  Harry J de Koning; Carlijn M van der Aalst; Pim A de Jong; Ernst T Scholten; Kristiaan Nackaerts; Marjolein A Heuvelmans; Jan-Willem J Lammers; Carla Weenink; Uraujh Yousaf-Khan; Nanda Horeweg; Susan van 't Westeinde; Mathias Prokop; Willem P Mali; Firdaus A A Mohamed Hoesein; Peter M A van Ooijen; Joachim G J V Aerts; Michael A den Bakker; Erik Thunnissen; Johny Verschakelen; Rozemarijn Vliegenthart; Joan E Walter; Kevin Ten Haaf; Harry J M Groen; Matthijs Oudkerk
Journal:  N Engl J Med       Date:  2020-01-29       Impact factor: 91.245

Review 6.  Radiomics: extracting more information from medical images using advanced feature analysis.

Authors:  Philippe Lambin; Emmanuel Rios-Velazquez; Ralph Leijenaar; Sara Carvalho; Ruud G P M van Stiphout; Patrick Granton; Catharina M L Zegers; Robert Gillies; Ronald Boellard; André Dekker; Hugo J W L Aerts
Journal:  Eur J Cancer       Date:  2012-01-16       Impact factor: 9.162

7.  Overdiagnosis in low-dose computed tomography screening for lung cancer.

Authors:  Edward F Patz; Paul Pinsky; Constantine Gatsonis; Jorean D Sicks; Barnett S Kramer; Martin C Tammemägi; Caroline Chiles; William C Black; Denise R Aberle
Journal:  JAMA Intern Med       Date:  2014-02-01       Impact factor: 21.873

8.  Radiomic features analysis in computed tomography images of lung nodule classification.

Authors:  Chia-Hung Chen; Chih-Kun Chang; Chih-Yen Tu; Wei-Chih Liao; Bing-Ru Wu; Kuei-Ting Chou; Yu-Rou Chiou; Shih-Neng Yang; Geoffrey Zhang; Tzung-Chi Huang
Journal:  PLoS One       Date:  2018-02-05       Impact factor: 3.240

9.  Reproducibility of radiomics for deciphering tumor phenotype with imaging.

Authors:  Binsheng Zhao; Yongqiang Tan; Wei-Yann Tsai; Jing Qi; Chuanmiao Xie; Lin Lu; Lawrence H Schwartz
Journal:  Sci Rep       Date:  2016-03-24       Impact factor: 4.379

10.  Novel high-resolution computed tomography-based radiomic classifier for screen-identified pulmonary nodules in the National Lung Screening Trial.

Authors:  Tobias Peikert; Fenghai Duan; Srinivasan Rajagopalan; Ronald A Karwoski; Ryan Clay; Richard A Robb; Ziling Qin; JoRean Sicks; Brian J Bartholmai; Fabien Maldonado
Journal:  PLoS One       Date:  2018-05-14       Impact factor: 3.240

View more
  4 in total

1.  Development and Validation of a Preoperative CT-Based Nomogram to Differentiate Invasive from Non-Invasive Pulmonary Adenocarcinoma in Solitary Pulmonary Nodules.

Authors:  Xin Song; Qingtao Zhao; Hua Zhang; Wenfei Xue; Zhifei Xin; Jianhua Xie; Xiaopeng Zhang
Journal:  Cancer Manag Res       Date:  2022-03-20       Impact factor: 3.989

Review 2.  Low-dose computed tomography lung cancer screening: Clinical evidence and implementation research.

Authors:  Harriet L Lancaster; Marjolein A Heuvelmans; Matthijs Oudkerk
Journal:  J Intern Med       Date:  2022-03-24       Impact factor: 13.068

3.  Identification of pulmonary adenocarcinoma and benign lesions in isolated solid lung nodules based on a nomogram of intranodal and perinodal CT radiomic features.

Authors:  Li Yi; Zhiwei Peng; Zhiyong Chen; Yahong Tao; Ze Lin; Anjing He; Mengni Jin; Yun Peng; Yufeng Zhong; Huifeng Yan; Minjing Zuo
Journal:  Front Oncol       Date:  2022-09-06       Impact factor: 5.738

4.  CT-Based Radiomics Nomogram for Differentiation of Anterior Mediastinal Thymic Cyst From Thymic Epithelial Tumor.

Authors:  Chengzhou Zhang; Qinglin Yang; Fan Lin; Heng Ma; Haicheng Zhang; Ran Zhang; Ping Wang; Ning Mao
Journal:  Front Oncol       Date:  2021-12-10       Impact factor: 6.244

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.